<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01661686</url>
  </required_header>
  <id_info>
    <org_study_id>COPAC</org_study_id>
    <nct_id>NCT01661686</nct_id>
  </id_info>
  <brief_title>Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures</brief_title>
  <acronym>COPAC</acronym>
  <official_title>A Randomized Comparison of a Fully Covered Self Expandable Metal Stent Versus a Partially Covered Self Expandable Metal Stent in Malignant Esophageal Strictures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foundation for Liver Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Foundation for Liver Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether fully covered or partially covered metal
      stents are more favorable in incurable malignant stenosis of the esophagus or cardia. Primary
      outcome will be the occurence of recurrent dysphagia which is defined as dysphagia due to a
      stent or tumour related cause in a 6-month follow-up
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent dysphagia.</measure>
    <time_frame>From stent placement (t=0) until death or placement of second stent, assessed up to 6 months.</time_frame>
    <description>This is defined as occurrence of dysphagia due to a stent or tumor related cause. These include tumor in- or overgrowth, stent migration, stent fracture or food impaction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success of SEMS placement</measure>
    <time_frame>At stent placement (t=0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical success defined as improvement of dysphagia score</measure>
    <time_frame>From stent placement until death or placement of second stent, assessed up to 6 months.</time_frame>
    <description>dysphagia scores will be obtained at time point: t=0, t= 1 week, t=2 weeks, t=1 month, t=3 months and t= 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major and minor complication rate</measure>
    <time_frame>From stent placement until death or placement of second stent, assessed up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>From stent placement until death or placement of second stent, assessed up to 6 months.</time_frame>
    <description>This will be assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30 and the EOS18, at time point: t=0, t= 1 week, t=2 weeks, t=1 month, t=3 months and t= 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>From stent placement until death or placement of second stent, assessed up to 6 months.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Esophageal Cancer</condition>
  <condition>Esophageal Stenosis</condition>
  <arm_group>
    <arm_group_label>Insertion of a partially covered SEMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Insertion of a Fully covered SEMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Partially covered SEMS</intervention_name>
    <description>Boston Scientific, Natick, United States diameter 18 mm, lengths of 10, 12 and 15 cm available</description>
    <arm_group_label>Insertion of a partially covered SEMS</arm_group_label>
    <other_name>WallFlex Partially covered esophageal stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fully covered SEMS</intervention_name>
    <description>Boston Scientific, Natick, United States diameter 18 mm, lengths of 10, 12 and 15 cm available</description>
    <arm_group_label>Insertion of a Fully covered SEMS</arm_group_label>
    <other_name>WallFlex Fully covered esophageal stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Malignant stricture of the esophagus or cardia

          -  No curative treatment options available

          -  Dysphagia grade of at least 2 (i.e. swallow semi-solid foods or less)

          -  Informed consent

          -  Age â‰¥ 18 years

        Exclusion Criteria:

          -  Previous treatment with self-expandable metal stent for same condition

          -  Evidence of tumor within 2 cm of the upper esophageal sphincter.

          -  Presence of an esophago-tracheal or -bronchial fistula or both.

          -  Not able to undergo upper endoscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco J Bruno, M.D., Prof</last_name>
    <role>Study Director</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IJsselland Hospital</name>
      <address>
        <city>Capelle a/d IJssel</city>
        <state>Zuid Holland</state>
        <zip>2900 AR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint Fransiscus Gasthuis</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3045 PM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ikazia Hospital</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3083 AN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Hospital</name>
      <address>
        <city>Zwijndrecht</city>
        <state>Zuid Holland</state>
        <zip>3331 LZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2012</study_first_submitted>
  <study_first_submitted_qc>August 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2012</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Foundation for Liver Research</investigator_affiliation>
    <investigator_full_name>Manon Spaander</investigator_full_name>
    <investigator_title>M.D., PhD</investigator_title>
  </responsible_party>
  <keyword>esophageal cancer</keyword>
  <keyword>esophageal stenosis</keyword>
  <keyword>stent</keyword>
  <keyword>endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Esophageal Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

